Alicia Valencia-Gutierrez
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Cost-utility analysis of benzodiazepine deprescription in primary care: a cohort study.
Journal: BMC health services research
Published: November 18, 2025
Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy.
Journal: Exploratory research in clinical and social pharmacy
Published: July 15, 2025
High-Dose Ceftriaxone in Elderly Patients with Enterococcal Infective Endocarditis: Population Pharmacokinetics of Free Ceftriaxone and Dose Optimization.
Journal: Antibiotics (Basel, Switzerland)
Published: April 14, 2025
Randomized clinical trial to evaluate the longitudinal HIV-1 reservoir and inflammation in treatment-naïve people starting dolutegravir/lamivudine versus dolutegravir plus tenofovir alafenamide/emtricitabine.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 09, 2025
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Journal: PloS one
Published: November 21, 2024
Mitochondrial Disorders After 12 Months of Human Immunodeficiency Virus Type 1 Preexposure Prophylaxis Based on Tenofovir Disoproxil Fumarate Plus Emtricitabine in Healthy Adults.
Journal: The Journal of infectious diseases
Published: September 17, 2024
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life.
Journal: Microbiology spectrum
Published: June 25, 2024
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1.
Journal: EBioMedicine
Published: May 08, 2024
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors.
Journal: Frontiers in immunology
Published: April 26, 2024
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.
Journal: Pharmaceutics
Published: November 04, 2023
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Journal: Frontiers in immunology
Published: July 12, 2023
HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2023
Last Updated: 09/26/2026